Showing results (251-260 of 261) with videos related to
Sort By:
Pageof 27
BMC Health Services Research|January 3, 2022
A public health value-based healthcare paradigm for HIVSebastian Vermeersch, Rémy P Demeester, Nathalie Ausselet, et al.European Heart Journal|September 3, 2014
EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoringHein Heidbuchel, Gerd Hindricks, Paul Broadhurst, et al.Preventive Medicine|July 16, 2021
Cost-effectiveness analysis of a school- and community-based intervention to promote a healthy lifestyle and prevent type 2 diabetes in vulnerable families across Europe: the Feel4Diabetes-studyRuben Willems, Konstantina Tsoutsoulopoulou, Ruben Brondeel, et al.Journal of Personalized Medicine|January 22, 2024
Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U ConsortiumKatharina Beyer, Renée Leenen, Lionne D F Venderbos, et al.BMC Endocrine Disorders|March 14, 2020
Methodology of the health economic evaluation of the Feel4Diabetes-studyRuben Willems, Lore Pil, Christina-Paulina Lambrinou, et al.International Journal of Cardiology|September 3, 2018
Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV surveyDelphine De Smedt, Lieven Annemans, Guy De Backer, et al.European Urology|August 25, 2024
Prostate Cancer Early Detection in the European Union and UKRenée C A Leenen, Lionne D F Venderbos, Jozien Helleman, et al.Journal of Personalized Medicine|July 27, 2024
Understanding the Barriers to Prostate Cancer Population-Based Early Detection Programs: The PRAISE-U BEST SurveyKatharina Beyer, Renée C A Leenen, Lionne D F Venderbos, et al.European Urology|May 24, 2024
Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in EuropePieter Vynckier, Lieven Annemans, Sarah Raes, et al.Journal of the American College of Cardiology|May 9, 2020
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES TrialDeepak L Bhatt, Andrew H Briggs, Shelby D Reed, et al.Pageof 27